{"id":"tp-44962","type":"article-newspaper","title":"Krystal Biotech Q3 Estimates Point to 29.4% Revenue Growth","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/44962","datePublished":"2026-10-30T17:45:02.000Z","dateModified":"2026-10-30T17:45:02.000Z","language":"en","abstract":"Earnings per share are estimated at $1.92, down 27.8% year over year. Results are due before U.S. markets open Monday, Nov. 2.","section":"Business","references":[]}